In vivo treatment with 1C5 prolongs skin allograft survival. Left: Schematic representation of the experimental procedures. Right: Wild-type C57BL/6 mice were i.p. injected 4 times with 250 µg 1C5 or C6 once in a week, followed by transplantation of ear skin from BALB/c mice. CyA (20 mg/kg) was injected every day after transplantation until the graft was rejected. Alloreactive IgG in sera was measured by FCM (top right). Mean ± SD are shown (n = 5). Data were analyzed by two-way ANOVA with Šidák multiple comparison test. Bottom right: graft survival curves (n = 20) are shown.
Autoimmune diabetes & #transplant rejection arise when immune checkpoints fail. This study shows that blocking CD22 ligand-binding expands regulatory #Bcells & protective γδ #Tcells, suppressing type 1 #diabetes & prolonging #SkinGraft survival in mice @plosbiology.org 🧪 plos.io/41t4KTS